Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 12, 2011, Pages 1674-1679

  Mowat, Eilidh ^a   Paterson, Steve ^a   Fothergill, Joanne L ^a,b   Wright, Elli A ^a   Ledson, Martin J ^c   Walshaw, Martin J ^c   Brockhurst, Michael A ^a   Winstanley, Craig ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Population biology; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; PYOCYANINE;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DYNAMICS; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; LUNG INFECTION; MALE; MICROBIAL DIVERSITY; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE; TURNOVER TIME;

ADULT; CHRONIC DISEASE; CYSTIC FIBROSIS; FEMALE; GENETIC VARIATION; HAPLOTYPES; HUMANS; LUNG DISEASES; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PYOCYANINE; SPUTUM;

EID: 80051561535     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201009-1430OC     Document Type: Article

References (43)

1. Hart CA, Winstanley C. Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull 2002;61:81-96. (Pubitemid 34477557)
2. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100. (Pubitemid 34809519)
3. Guilbault C, Martin P, Houle D, Boghdady ML, Guiot MC, Marion D, Radzioch D. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Lab Anim 2005;39:336-352. (Pubitemid 41058541)
4. Potvin E, Lehoux DE, Kukavica-Ibrulj I, Richard KL, Sanschagrin F, Lau GW, Levesque RC. In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol 2003;5:1294-1308. (Pubitemid 38038941)
5. Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis. Infect Immun 2003;71:2404-2413. (Pubitemid 36519851)
6. Alibaud L, Kohler T, Coudray A, Prigent-Combaret C, Bergeret E, Perrin J, Benghezal M, Reimmann C, Gauthier Y, van Delden C, et al. Pseudomonas aeruginosa virulence genes identified in a Dictyostelium host model. Cell Microbiol 2008;10:729-740. (Pubitemid 351194098)
7. Tan MW, Rahme LG, Sternberg JA, Tompkins RG, Ausubel FM. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci USA 1999;96:2408-2413. (Pubitemid 29117928)
8. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2000;2:1051-1060. (Pubitemid 30664219)
9. Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996;60:539-574. (Pubitemid 26303478)
10. Moreau-Marquis S, Stanton BA, O'Toole GA. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulm Pharmacol Ther 2008;21:595-599. (Pubitemid 351970710)
11. Foweraker JE, Laughton CR, Brown DF, Bilton D. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. J Antimicrob Chemother 2005;55:921-927. (Pubitemid 40883177)
12. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 2006;103:8487-8492. (Pubitemid 43838482)
13. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, Di SC, Doring G, Tümmler B. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 2009;180:138-145.
14. Winstanley C, Fothergill JL. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol Lett 2009;290:1-9.
15. D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Deziel E, Smith EE, Nguyen H, Ernst RK, Larson-Freeman TJ, Spencer DH, et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 2007;64:512-533. (Pubitemid 46632635)
16. Armstrong D, Bell S, Robinson M, Bye P, Rose B, Harbour C, Lee C, Service H, Nissen M, Syrmis M, et al. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol 2003;41:2266-2267. (Pubitemid 36576585)
17. Brimicombe RW, Dijkshoorn L, van der Reijden TJ, Kardoes I, Pitt TL, van den Broek PJ, Heijerman HG. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. J Cyst Fibros 2008;7:30-36.
18. Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996;348:639-642. (Pubitemid 26293808)
19. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001;358:557-558. (Pubitemid 32772734)
20. O'Carroll MR, Syrmis MW, Wainwright CE, Greer RM, Mitchell P, Coulter C, Sloots TP, Nissen MD, Bell SC. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 2004;24:101-106. (Pubitemid 39029075)
21. Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 2004;53:609-615. (Pubitemid 38932357)
22. Edenborough FP, Stone HR, Kelly SJ, Zadik P, Doherty CJ, Govan JR. Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation. J Cyst Fibros 2004;3:37-44. (Pubitemid 38397022)
23. Fothergill JL, White J, Foweraker JE, Walshaw MJ, Ledson MJ, Mahenthiralingam E, Winstanley C. Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infections. J Clin Microbiol 2010;48:2053-2059.
24. Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, Winstanley C. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol 2007;7:45.
25. Fothergill JL, Mowat E, Ledson MJ, Walshaw MJ, Winstanley C. Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations. J Med Microbiol 2010;59:472-481.
26. Carter ME, Fothergill JL, Walshaw MJ, Rajakumar K, Kadioglu A, Winstanley C. A subtype of a Pseudomonas aeruginosa cystic fibrosis epidemic strain exhibits enhanced virulence in a murine model of acute respiratory infection. J Infect Dis 2010;202:935-942.
27. Thomas SR, Ray A, Hodson ME, Pitt TL. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 2000;55:795-797. (Pubitemid 30660910)
28. Oliver A, Canton R, Campo P, Baquero F, Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000;288:1251-1254.
29. Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, Sanschagrin F, Thomson NR, Winsor GL, Quail MA, Lennard N, et al. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool epidemic strain of Pseudomonas aeruginosa. Genome Res 2009;19:12-23.
30. Mowat E, Fothergill JL, Ledson MJ, Walshaw MJ, Paterson S, Brockhurst MA, Winstanley C. Populations of the Pseudomonas aeruginosa Liverpool epidemic strain are highly diverse and fluctuate in chronicallyinfected cystic fibrosis patients [abstract]. J Cyst Fibros 2010;9:S29.
31. Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1. Epidemiology and pathogenesis. Thorax 2007;62:360-367. (Pubitemid 46580580)
32. De Vos D, Lim A Jr, Pirnay JP, Struelens M, Vandenvelde C, Duinslaeger L, Vanderkelen A, Cornelis P. Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL. J Clin Microbiol 1997;35:1295-1299. (Pubitemid 27216783)
33. Fothergill JL, Upton AL, Pitt TL, Hart CA, Winstanley C. Diagnostic multiplex PCR assay for the identification of the Liverpool, Midlands 1 and Manchester CF epidemic strains of Pseudomonas aeruginosa. J Cyst Fibros 2008;7:258-261. (Pubitemid 351650270)
34. Dray S, Dufour AB. The ade4 package: implementing the duality diagram for ecologists. J Stat Softw 2007;22:1-20.
35. R Development Core Team. (R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2010. Available from: http://www.R-project.org
36. Rousset F. Genetic differentiation and estimation of gene flow from F statistics under isolation by distance. Genetics 1997;145:1219-1228. (Pubitemid 27149123)
37. Salunkhe P, Smart CH, Morgan JAW, Panagea S, Walshaw MJ, Hart CA, Geffers R, Tümmler B, Winstanley C. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 2005;187:4908-4920. (Pubitemid 40962208)
38. Rakhimova E, Munder A, Wiehlmann L, Bredenbruch F, Tümmler B. Fitness of isogenic colony morphology variants of Pseudomonas aeruginosa in murine airway infection. PLoS One 2008;3:e1685.
39. Girard G, Bloemberg GV. Central role of quorum sensing in regulating the production of pathogenicity factors in Pseudomonas aeruginosa. Future Microbiol 2008;3:97-106. (Pubitemid 351395067)
40. Wilder CN, Allada G, Schuster M. Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect Immun 2009;77:5631-5639.
41. Ryall B, Davies JC, Wilson R, Shoemark A, Williams HD. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients. Eur Respir J 2008;32:740-747.
42. Al Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 2004;59:334-336. (Pubitemid 38496753)
43. Aaron SD, Vandemheen KL, Ramotar K, Giesbrecht-Lewis T, Tullis E, Freitag A, Paterson N, Jackson M, Lougheed MD, Dowson C, et al. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. JAMA 2010;304:2145-2153.